What the heart team is actually comparing
Aortic stenosis is a narrowing of the aortic valve that can obstruct blood flow out of the heart. Once the decision to intervene has been made, the practical question becomes how to replace or relieve that valve: through a catheter-based procedure such as TAVR (also called TAVI), or through open surgical aortic valve replacement. These are different operations with different recovery patterns and different risk profiles, and the right answer is individual.
Current guidance from major cardiac societies frames this as a shared decision made by a multidisciplinary heart team rather than by a single clinician. The team typically includes cardiologists, cardiac surgeons and imaging specialists, and it reviews the same evidence together. The patient's own goals and preferences are part of that discussion, not an afterthought.
The comparison is not simply 'less invasive versus more invasive'. TAVR avoids a full sternotomy and the heart-lung machine, but it carries its own procedural risks, including stroke, vascular complications, bleeding, paravalvular leak and the need for a permanent pacemaker in some patients. Surgery offers a directly inspected and often durable valve, but involves open-heart operation, cardiopulmonary bypass and a longer initial recovery. Neither list is a reason to choose one route without the team's assessment.
The clinical factors that usually shape the recommendation
Several categories of information carry weight. The first is the severity of the valve disease and whether it is causing symptoms or measurable strain on the heart. Guidelines generally distinguish patients with symptoms or reduced heart function from those without, because the threshold for intervention differs.
The second is the patient's estimated surgical risk. Teams consider age, frailty, other heart disease, lung disease, kidney function, prior chest surgery and general functional status. A patient judged at high or prohibitive surgical risk is more likely to be offered TAVR, while a patient at low surgical risk may be offered either route depending on anatomy and preference. These categories are clinical judgements, not fixed cut-offs a patient can apply alone.
The third is anatomy. The size and shape of the aortic valve, the distribution of calcium, the access vessels used to reach the heart, and the distance from the valve to the coronary arteries all influence whether a catheter-based valve can be seated safely. Some anatomies are favourable for TAVR; others make surgery the more reliable option. This is why imaging is central to the decision.
The fourth is durability and expected lifespan. For younger patients with a long expected lifespan, the long-term performance of the replacement and the possibility of future procedures matter. For older or frailer patients, the immediate risk of the procedure may weigh more heavily. Guidelines discuss these trade-offs but do not reduce them to a single age rule.
Records that help a receiving team assess suitability
A useful starting file lets the heart team see the valve and the whole patient. The exact list a hospital requires is confirmed by that hospital, but the following are commonly relevant items to ask about and to gather where available.
An echocardiogram report is central, ideally with the images as well as the measurements. It describes the valve, the degree of stenosis, the heart's pumping function and any other valve disease. A recent ECG and any rhythm monitoring help the team understand conduction issues, which matter for TAVR planning. Cardiac CT is often used to assess the aortic valve and access anatomy before a catheter-based procedure, and the team will say whether it is needed.
Coronary angiography or CT coronary imaging may be requested to check for coronary artery disease that needs attention. Blood tests, lung function and a record of other conditions and medicines complete the picture. Prior operation notes and any earlier valve procedure are important, because a previous sternotomy changes the surgical picture.
Patients should not assume a test is mandatory or unnecessary before the team has reviewed the file. The right approach is to send what exists, note what is missing, and ask the receiving clinicians which additional studies they require for their own assessment.
Questions worth asking before committing to a route
The value of a consultation lies partly in the questions the patient brings. A patient can ask the team to explain, in plain terms, why one route is being recommended over the other for their specific anatomy and risk profile. It is reasonable to ask what the main risks of each option are, how the team weighs them, and what would change the recommendation.
Patients can also ask about the expected durability of the proposed valve and what future options might exist if it fails. For TAVR, it is reasonable to ask about the risk of paravalvular leak, stroke and pacemaker need, and how the team plans to manage them. For surgery, questions about the type of valve, the use of the heart-lung machine and the expected recovery course are appropriate.
Because this is a shared decision, patients should feel able to say what matters to them: avoiding a long hospital stay, returning to work, or minimising the chance of a repeat procedure. The team can then explain how those priorities fit the clinical evidence. No article can make the choice for an individual patient, and a records-based opinion does not replace the treating hospital's own assessment and consent process.
How planning for care in China fits around the decision
For an international patient, the clinical decision comes first and the logistics follow. A hospital will need to review the records before it can say whether it can offer TAVR, surgery or both, and which team would lead the assessment. Confirming that a centre performs both routes, and how its heart team is organised, is a sensible question for the receiving hospital rather than an assumption.
ChinaSpecialistCare can help with non-clinical coordination: matching a patient's question to a relevant cardiac team, preparing a records summary, and arranging an appointment or a records-based review where appropriate. The initial case review is free and is not a diagnosis or a promise of acceptance. A proxy consultation, in which a doctor takes records to a hospital specialist while the patient remains at home, is optional and not a prerequisite for an appointment or operation. Hospital consultation, test and treatment fees are separate from coordination fees, and the hospital's written plan and quote should be confirmed directly.
The next practical step is to gather the echocardiogram report and images, recent ECG, any cardiac CT or angiography, and a list of current medicines, then send a short summary through the enquiry form, email or WhatsApp. The team can then indicate what is missing and which questions to put to the cardiac team. Worsening symptoms such as chest pain, breathlessness at rest or fainting should be assessed locally without waiting for overseas planning.
Sources & scope of this guide
References and official service information relevant to this guide.
- Related treatment reference
- Heart valve replacement - NHS
- 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guideli
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
